Treatment of High Risk Periodontal Patients
Pp. 240-257 (18)
High-risk periodontal patients respond susceptible to inflammation with the
risk-determining factors occurring on a molecular level that cannot be altered.
Successful therapy of periodontal risk patients requires medical assessment of clinical,
microbial and immunological laboratory parameters including regular maintenance.
High-risk patients are incorporated into a comprehensive medical and dental treatment
plan with focus on preventive planning. If you need informations about treatment
solutions for patients at medical or periodontal risk, if you want to advise your patients
more comprehensively or simply want to refer your patients with more expertise and
knowledge, then read on.
Arachidonic acid, Betamethasone valerate, Chlorhexidine varnish,
Client-centered, Collagenase, Copayment, Doxycyclin, Family members,
Glycation, Halitosis, Hyperresponse, Immunomodulation, Leukocytes, Liability,
Management, Oral dryness, Periostat, Priming, Prostaglandins, Snoring,
Susceptibility, True risk factor.
Division of Periodontology, Medical Faculty, University of Düsseldorf, Moorenstrasse 5, Düsseldorf, NRW 40225, Germany.